2024 Q4 Form 10-Q Financial Statement

#000095017024128808 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.225M
YoY Change 2.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $474.0K
YoY Change -9.89%
% of Gross Profit
Operating Expenses $4.525M
YoY Change -0.37%
Operating Profit -$300.0K
YoY Change -25.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$682.0K
YoY Change 19.86%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$982.0K
YoY Change 0.92%
Net Earnings / Revenue -23.24%
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$0.52
COMMON SHARES
Basic Shares Outstanding 1.879M 1.904M
Diluted Shares Outstanding 1.904M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $500.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $2.034M
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $39.43M
YoY Change -13.92%
Goodwill $1.585M
YoY Change 0.0%
Intangibles $11.52M
YoY Change -3.57%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $60.06M
YoY Change -6.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $49.66M
YoY Change -3.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $49.66M
YoY Change -3.35%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $49.66M
Total Liabilities $62.44M
YoY Change -1.86%
SHAREHOLDERS EQUITY
Retained Earnings -$84.60M
YoY Change 3.6%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.380M
YoY Change
Total Liabilities & Shareholders Equity $60.06M
YoY Change -6.17%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$982.0K
YoY Change 0.92%
Depreciation, Depletion And Amortization $474.0K
YoY Change -9.89%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001004724
dei Entity Registrant Name
EntityRegistrantName
REGIONAL HEALTH PROPERTIES, INC.
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33135
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5166048
dei Entity Address Address Line1
EntityAddressAddressLine1
1050 Crown Pointe Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 720
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30338
dei City Area Code
CityAreaCode
678
dei Local Phone Number
LocalPhoneNumber
869-5116
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1879249
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39429000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40398000
CY2024Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
4851000
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
4939000
CY2024Q3 us-gaap Cash
Cash
497000
CY2023Q4 us-gaap Cash
Cash
953000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
3005000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3231000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2186000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2040000
CY2024Q3 us-gaap Receivables From Customers
ReceivablesFromCustomers
2034000
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
1403000
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
663000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
613000
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
594000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1044000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2024Q3 rhe Finite Lived Intangible Assets Lease Rights Net
FiniteLivedIntangibleAssetsLeaseRightsNet
74000
CY2023Q4 rhe Finite Lived Intangible Assets Lease Rights Net
FiniteLivedIntangibleAssetsLeaseRightsNet
87000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2263000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2556000
CY2024Q3 us-gaap Goodwill
Goodwill
1585000
CY2023Q4 us-gaap Goodwill
Goodwill
1585000
CY2024Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
2594000
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
2901000
CY2024Q3 us-gaap Assets
Assets
60060000
CY2023Q4 us-gaap Assets
Assets
62181000
CY2024Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
39509000
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
40401000
CY2024Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
3354000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
3454000
CY2024Q3 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
5849000
CY2023Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
5991000
CY2024Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
945000
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
889000
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3707000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2493000
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4703000
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4060000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2592000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2917000
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
1781000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
1791000
CY2024Q3 us-gaap Liabilities
Liabilities
62440000
CY2023Q4 us-gaap Liabilities
Liabilities
61996000
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1890000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1879000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1850000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1839000
CY2024Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
63144000
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
63059000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84552000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81902000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-2380000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
185000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60060000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62181000
CY2024Q3 us-gaap Revenues
Revenues
4225000
CY2023Q3 us-gaap Revenues
Revenues
4138000
us-gaap Revenues
Revenues
12675000
us-gaap Revenues
Revenues
12642000
CY2024Q3 rhe Patient Care Expense
PatientCareExpense
2179000
CY2023Q3 rhe Patient Care Expense
PatientCareExpense
2153000
rhe Patient Care Expense
PatientCareExpense
6462000
rhe Patient Care Expense
PatientCareExpense
6444000
CY2024Q3 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2023Q3 rhe Facility Rent Expense
FacilityRentExpense
149000
rhe Facility Rent Expense
FacilityRentExpense
446000
rhe Facility Rent Expense
FacilityRentExpense
446000
CY2023Q3 rhe Cost Of Management Fees
CostOfManagementFees
156000
rhe Cost Of Management Fees
CostOfManagementFees
442000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
526000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1499000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1738000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1224000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1329000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4085000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4284000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
499000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
229000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
563000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4525000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4542000
us-gaap Operating Expenses
OperatingExpenses
13055000
us-gaap Operating Expenses
OperatingExpenses
13623000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-300000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-404000
us-gaap Operating Income Loss
OperatingIncomeLoss
-380000
us-gaap Operating Income Loss
OperatingIncomeLoss
-981000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
677000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
708000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2021000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2066000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-249000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-682000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-569000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2270000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2669000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-982000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-973000
us-gaap Profit Loss
ProfitLoss
-2650000
us-gaap Profit Loss
ProfitLoss
-3650000
rhe Preferred Stock Dividends Gain On Extinguishment
PreferredStockDividendsGainOnExtinguishment
43395000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-982000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-973000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2650000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39745000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.18
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
21.18
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1904028
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1883028
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1863314
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1876138
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1904028
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1883028
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1863314
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1876138
CY2023Q4 rhe Shares Issued Net
SharesIssuedNet
4640000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-962000
CY2024Q1 rhe Shares Issued Net
SharesIssuedNet
4640000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-734000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000
CY2024Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
65000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-706000
CY2024Q2 rhe Shares Issued Net
SharesIssuedNet
4705000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1417000
CY2024Q3 rhe Stock Based Compensation Net Of Forfeitures
StockBasedCompensationNetOfForfeitures
19000
CY2024Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
25000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-982000
CY2024Q3 rhe Shares Issued Net
SharesIssuedNet
4680000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2380000
CY2022Q4 rhe Shares Issued Net
SharesIssuedNet
4587000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3716000
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
99000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1992000
CY2023Q1 rhe Shares Issued Net
SharesIssuedNet
4686000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1805000
CY2023Q2 rhe Extinguishment Of Preferred Stock Shares
ExtinguishmentOfPreferredStockShares
2252000
CY2023Q2 rhe Extinguishment Of Preferred Stock Value
ExtinguishmentOfPreferredStockValue
-61997000
CY2023Q2 rhe Exchange Of Preferred Stock Shares
ExchangeOfPreferredStockShares
2252000
CY2023Q2 rhe Adjustment Of Exchange Of Preferred Stock Value
AdjustmentOfExchangeOfPreferredStockValue
61997000
CY2023Q2 rhe Stock Based Compensation Net Of Forfeitures
StockBasedCompensationNetOfForfeitures
155000
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
2000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-685000
CY2023Q2 rhe Shares Issued Net
SharesIssuedNet
4684000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1275000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-973000
CY2023Q3 rhe Shares Issued Net
SharesIssuedNet
4684000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
387000
us-gaap Profit Loss
ProfitLoss
-2650000
us-gaap Profit Loss
ProfitLoss
-3650000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1499000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1738000
us-gaap Share Based Compensation
ShareBasedCompensation
85000
us-gaap Share Based Compensation
ShareBasedCompensation
321000
rhe Rent Expense Less Than In Excess Of Cash Paid
RentExpenseLessThanInExcessOfCashPaid
-32000
rhe Rent Expense Less Than In Excess Of Cash Paid
RentExpenseLessThanInExcessOfCashPaid
-18000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-330000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-298000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
56000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
56000
rhe Write Off Of Straight Line Receivable
WriteOffOfStraightLineReceivable
164000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
563000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
327000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4053000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-115000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1157000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-4000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1855000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-739000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-8000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
575000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
990000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3460000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
430000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
916000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-430000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-916000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1025000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
988000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
200000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
813000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
17000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
17000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1242000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1818000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-682000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
726000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3909000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3502000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4635000
us-gaap Interest Paid Net
InterestPaidNet
1978000
us-gaap Interest Paid Net
InterestPaidNet
2004000
rhe Vendor Financed Insurance
VendorFinancedInsurance
711000
rhe Vendor Financed Insurance
VendorFinancedInsurance
962000
rhe Exchange Of Preferred Stock Series A To Series B
ExchangeOfPreferredStockSeriesAToSeriesB
18602000
rhe Preferred Stock Dividends Gain On Extinguishment
PreferredStockDividendsGainOnExtinguishment
43395000
rhe Account Receivable Converted To Note Receivable
AccountReceivableConvertedToNoteReceivable
312000
rhe Building Improvements Financed With Note Payable
BuildingImprovementsFinancedWithNotePayable
78000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period's presentation. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A reclassification has been made to certain expenses reported on the consolidated statements of operations in the prior period in order to conform to the current period's presentation. The reclassifications had no material effect on earnings per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 rhe Percentage Of Reserve For Patient Care Revenue
PercentageOfReserveForPatientCareRevenue
0.015
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2000000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1400000
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4220000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3443000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2186000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2040000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2034000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1403000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
100000
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3707000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
2493000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
89000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
70000
CY2024Q3 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1000000
rhe Accumulated And Unpaid Dividends On Series A Preferred Stock
AccumulatedAndUnpaidDividendsOnSeriesAPreferredStock
50400000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
49700000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1000000
CY2024Q3 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
2200000
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
As of September 30, 2024, the Company was in compliance with the various financial and administrative covenants under the Company's outstanding credit related instruments with the exception of a notice of default under two USDA loans secured by the Southland and Mt. Trace Property and an SBA loan secured by Southland. On October 25, 2024, the Company received a notice of acceleration and demand for payment from the lenders of Southland stating that the covenants of the deed of trust have been violated for failure to pay principal and interest. The lender accelerated the maturity dates and is requesting for the loans to be paid in full plus unpaid interest and late fees immediately. We are working with the lender to reach a forbearance agreement and think it is likely we will reach an agreement. On November 8, 2024, Company obtained a line of credit and intends to pay all unpaid principal and interest payments to get back into compliance with the loan documents. The Company is working with the lender of the Mt. Trace Property to get back into compliance with the loan documents and received a waiver in November 2024.
CY2024Q3 us-gaap Cash
Cash
500000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84600000
us-gaap Profit Loss
ProfitLoss
-2700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1000000
CY2024Q3 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
4100000
us-gaap Debt Default Longterm Debt Description Of Notice Of Default
DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault
On October 25, 2024, the Company received a notice of acceleration and demand for payment from the lenders of Southland stating that the covenants of the deed of trust have been violated for failure to pay principal and interest.
CY2024Q3 us-gaap Cash
Cash
497000
CY2023Q4 us-gaap Cash
Cash
953000
CY2024Q3 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
81000
CY2023Q4 rhe Pledged Assets Not Separately Reported Other Financial Instrument
PledgedAssetsNotSeparatelyReportedOtherFinancialInstrument
159000
CY2024Q3 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1998000
CY2023Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2125000
CY2024Q3 us-gaap Escrow Deposit
EscrowDeposit
607000
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
630000
CY2024Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
318000
CY2023Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
3005000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
3231000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3502000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4184000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63879000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63469000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24450000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23071000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39429000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40398000
CY2024Q3 us-gaap Land Improvements
LandImprovements
100000
CY2024Q3 us-gaap Depreciation
Depreciation
373000
CY2023Q3 us-gaap Depreciation
Depreciation
416000
us-gaap Depreciation
Depreciation
1182000
us-gaap Depreciation
Depreciation
1409000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
317000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
329000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
526000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1499000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1738000
rhe Assets Held For Sale Textblock
AssetsHeldForSaleTextblock
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTE 5. ASSETS HELD FOR SALE</span></p>
CY2024Q3 rhe Accumulated Depreciation Depletion And Amortization Asset Held For Sale
AccumulatedDepreciationDepletionAndAmortizationAssetHeldForSale
2374000
CY2023Q4 rhe Accumulated Depreciation Depletion And Amortization Asset Held For Sale
AccumulatedDepreciationDepletionAndAmortizationAssetHeldForSale
2286000
CY2024Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
4851000
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
4939000
CY2023Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16923000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5086000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11837000
CY2023Q4 us-gaap Goodwill
Goodwill
1585000
CY2024Q3 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16923000
CY2024Q3 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5404000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11519000
CY2024Q3 us-gaap Goodwill
Goodwill
1585000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
317000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
329000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueRemainderOfFiscalYear
170000
CY2024Q3 rhe Lessee Operating Lease Accretion On Lease Liability Due Remainder Of Fiscal Year
LesseeOperatingLeaseAccretionOnLeaseLiabilityDueRemainderOfFiscalYear
50000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
120000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
672000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
175000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
497000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
658000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
134000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
524000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
671000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
91000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
581000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
685000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
42000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
643000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFive
230000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFive
2000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
227000
CY2024Q3 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
3086000
CY2024Q3 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
494000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2592000
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0385
rhe Number Of Owned Facilities Lessor
NumberOfOwnedFacilitiesLessor
9
rhe Number Of Owned Facilities
NumberOfOwnedFacilities
11
rhe Number Of Owned Facilities Sub Lessor
NumberOfOwnedFacilitiesSubLessor
1
rhe Number Of Sublease Agreements Executed Owned By Company
NumberOfSubleaseAgreementsExecutedOwnedByCompany
10
rhe Weighted Average Remaining Lease Term Facilities Lessor
WeightedAverageRemainingLeaseTermFacilitiesLessor
P4Y7M6D
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
1525000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
6141000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
6233000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
6327000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
6161000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
8127000
CY2024Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
34514000
CY2024Q3 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
431000
CY2023Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
255000
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3437000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3077000
CY2024Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
8000
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
61000
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
217000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
225000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98000
CY2024Q3 rhe Insurance Escrow Current
InsuranceEscrowCurrent
155000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
455000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
344000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4703000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4060000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50670000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
51802000
CY2024Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
903000
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
954000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
109000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
113000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49658000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
50735000
CY2024Q3 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
622000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2464000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
8829000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
1560000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
1657000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
35538000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50670000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
109000
CY2024Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
903000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
49658000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1879249
CY2024Q3 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
19000
CY2023Q3 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
85000
rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
85000
rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
321000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
200000
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
57000
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y6M
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
9.41
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
44000
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
11.55
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
(i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company's management of three facilities on behalf of third-party owners; and (ii) Healthcare Services, which consists of the operation of the Meadowood and Glenvue facilities.
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1640000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1739000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5257000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5170000
CY2024Q3 us-gaap Revenues
Revenues
4225000
CY2023Q3 us-gaap Revenues
Revenues
4138000
us-gaap Revenues
Revenues
12675000
us-gaap Revenues
Revenues
12642000
CY2024Q3 rhe Patient Care Expense
PatientCareExpense
2179000
CY2023Q3 rhe Patient Care Expense
PatientCareExpense
2153000
rhe Patient Care Expense
PatientCareExpense
6462000
rhe Patient Care Expense
PatientCareExpense
6444000
CY2024Q3 rhe Facility Rent Expense
FacilityRentExpense
149000
CY2023Q3 rhe Facility Rent Expense
FacilityRentExpense
149000
rhe Facility Rent Expense
FacilityRentExpense
446000
rhe Facility Rent Expense
FacilityRentExpense
446000
CY2023Q3 rhe Cost Of Management Fees
CostOfManagementFees
156000
rhe Cost Of Management Fees
CostOfManagementFees
442000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
526000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1499000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1738000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1224000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1329000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4085000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4284000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
499000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
229000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
563000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4525000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4542000
us-gaap Operating Expenses
OperatingExpenses
13055000
us-gaap Operating Expenses
OperatingExpenses
13623000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-300000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-404000
us-gaap Operating Income Loss
OperatingIncomeLoss
-380000
us-gaap Operating Income Loss
OperatingIncomeLoss
-981000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
677000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
708000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2021000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2066000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-249000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-682000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-569000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2270000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2669000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-982000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-973000
us-gaap Net Income Loss
NetIncomeLoss
-2650000
us-gaap Net Income Loss
NetIncomeLoss
-3650000
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-128808-index-headers.html Edgar Link pending
0000950170-24-128808-index.html Edgar Link pending
0000950170-24-128808.txt Edgar Link pending
0000950170-24-128808-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-20240930.htm Edgar Link pending
rhe-20240930.xsd Edgar Link pending
rhe-ex31_1.htm Edgar Link pending
rhe-ex31_2.htm Edgar Link pending
rhe-ex32_1.htm Edgar Link pending
rhe-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rhe-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable